• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

TC21/R-ras2 在高度侵袭性恶性皮肤癌中表达更高。

Greater expression of TC21/R-ras2 in highly aggressive malignant skin cancer.

机构信息

Department of Plastic and Reconstructive Surgery, Hanyang University Guri Hospital, Guri, Korea.

出版信息

Int J Dermatol. 2011 Aug;50(8):956-60. doi: 10.1111/j.1365-4632.2010.04846.x.

DOI:10.1111/j.1365-4632.2010.04846.x
PMID:21781067
Abstract

BACKGROUND

TC21 plays an important role in highly aggressive tumor formation, and it was overexpressed in several human cancers, including breast cancer, oral squamous cell carcinoma (SCC), and esophageal SCC. In light of this, we explored the expression of TC21 in overall skin cancers in order to evaluate the relationship between TC21 and malignant skin tumors.

METHODS

We examined six normal skin tissues and 18 malignant skin tumor tissues, including six malignant melanomas (MM), six SCCs, and six basal cell carcinomas (BCCs) using western blotting for the expression of TC21. In another set, 16 specimens of MM, 16 SCC, and 16 BCC were analyzed for the expression of TC21 using immunohistochemical staining. To evaluate the amount of expression of TC21, the Raytest TINA software was used for western blotting and a histochemical score (HSCORE) was used for immunohistochemical evaluation.

RESULTS

The western blotting and immunohistochemistry showed that TC21 was expressed in all malignant skin tumors and not in normal skin tissues. The relative protein expression was an average of 0.004 in normal skin, 1.042 in MM, 0.621 in SCC, and 0.485 in BCC. In immunohistochemistry, HSCORE for normal skin was an average of 0.05, MM was 2.42, SCC was 2.11, and BCC was 1.22.

CONCLUSIONS

This article is the first study demonstrating expression of TC21 in human skin malignant tumors and suggests that TC21 is more expressed in highly aggressive skin tumors.

摘要

背景

TC21 在高度侵袭性肿瘤形成中发挥重要作用,它在包括乳腺癌、口腔鳞状细胞癌(SCC)和食管 SCC 在内的几种人类癌症中过度表达。有鉴于此,我们探索了 TC21 在所有皮肤癌中的表达,以评估 TC21 与恶性皮肤肿瘤之间的关系。

方法

我们使用 Western blot 检查了 6 个正常皮肤组织和 18 个恶性皮肤肿瘤组织,包括 6 个恶性黑色素瘤(MM)、6 个 SCC 和 6 个基底细胞癌(BCC),以检测 TC21 的表达。在另一组中,我们使用免疫组织化学染色分析了 16 个 MM、16 个 SCC 和 16 个 BCC 标本中 TC21 的表达。为了评估 TC21 的表达量,我们使用 Raytest TINA 软件进行 Western blot 分析,并使用组织化学评分(HSCORE)进行免疫组织化学评估。

结果

Western blot 和免疫组化显示 TC21 在所有恶性皮肤肿瘤中表达,而在正常皮肤组织中不表达。相对蛋白表达在正常皮肤中平均为 0.004,在 MM 中为 1.042,在 SCC 中为 0.621,在 BCC 中为 0.485。在免疫组化中,正常皮肤的 HSCORE 平均为 0.05,MM 为 2.42,SCC 为 2.11,BCC 为 1.22。

结论

本文首次研究表明 TC21 在人类皮肤恶性肿瘤中表达,并表明 TC21 在高度侵袭性皮肤肿瘤中表达更高。

相似文献

1
Greater expression of TC21/R-ras2 in highly aggressive malignant skin cancer.TC21/R-ras2 在高度侵袭性恶性皮肤癌中表达更高。
Int J Dermatol. 2011 Aug;50(8):956-60. doi: 10.1111/j.1365-4632.2010.04846.x.
2
Expression of RUNX3 in skin cancers.RUNX3 在皮肤癌中的表达。
Clin Exp Dermatol. 2011 Oct;36(7):769-74. doi: 10.1111/j.1365-2230.2011.04069.x. Epub 2011 May 30.
3
Immunohistochemical galectin-3 expression in non-melanoma skin cancers.非黑色素瘤皮肤癌中半乳糖凝集素-3的免疫组化表达
Pathol Res Pract. 2009;205(2):97-103. doi: 10.1016/j.prp.2008.09.001. Epub 2008 Oct 31.
4
Proteinase-activated receptor-2 expression in basal and squamous cell carcinomas compared with normal skin.与正常皮肤相比,蛋白酶激活受体-2在基底细胞癌和鳞状细胞癌中的表达。
J Cutan Pathol. 2009 Mar;36(3):314-7. doi: 10.1111/j.1600-0560.2008.01018.x. Epub 2008 Nov 19.
5
Immunohistochemical expression of ezrin in cutaneous basal and squamous cell carcinomas.免疫组化 Ezrin 在皮肤基底细胞癌和鳞状细胞癌中的表达。
Ann Diagn Pathol. 2011 Dec;15(6):394-401. doi: 10.1016/j.anndiagpath.2011.05.005. Epub 2011 Aug 16.
6
TC21/R-Ras2 upregulation in esophageal tumorigenesis: potential diagnostic implications.TC21/R-Ras2在食管肿瘤发生中的上调:潜在的诊断意义。
Oncology. 2005;69(1):10-8. doi: 10.1159/000087283. Epub 2005 Jul 28.
7
Heat shock protein 105 is overexpressed in squamous cell carcinoma and extramammary Paget disease but not in basal cell carcinoma.热休克蛋白105在鳞状细胞癌和乳腺外佩吉特病中过表达,但在基底细胞癌中不表达。
Br J Dermatol. 2006 Sep;155(3):582-5. doi: 10.1111/j.1365-2133.2006.07362.x.
8
Significance of PC cell-derived growth factor and cyclin D1 expression in cutaneous squamous cell carcinoma.PC 细胞衍生生长因子和细胞周期蛋白 D1 在皮肤鳞状细胞癌中的表达意义。
Clin Exp Dermatol. 2012 Jun;37(4):411-7. doi: 10.1111/j.1365-2230.2011.04275.x. Epub 2012 Mar 15.
9
High numbers of human skin cancers express MMP2 and several integrin genes.大量的人类皮肤癌表达基质金属蛋白酶2和几种整合素基因。
J Cutan Pathol. 2008 Mar;35(3):285-91. doi: 10.1111/j.1600-0560.2007.00810.x.
10
Clinical significance of TC21 overexpression in oral cancer.TC21 在口腔癌中的过表达的临床意义。
J Oral Pathol Med. 2010 Jul;39(6):477-85. doi: 10.1111/j.1600-0714.2009.00854.x. Epub 2009 Dec 16.

引用本文的文献

1
The ancestral type of the R-RAS protein has oncogenic potential.R-RAS 蛋白的原始类型具有致癌潜能。
Cell Mol Biol Lett. 2024 Feb 21;29(1):27. doi: 10.1186/s11658-024-00546-0.
2
Mice Overexpressing Wild-Type Are a Novel Model for Preclinical Testing of Anti-Chronic Lymphocytic Leukemia Therapies.过表达野生型的小鼠是抗慢性淋巴细胞白血病疗法临床前测试的新型模型。
Cancers (Basel). 2023 Dec 12;15(24):5817. doi: 10.3390/cancers15245817.
3
Characterization of Three Somatic Mutations in the 3'UTR of and Their Inverse Correlation with Lymphocytosis in Chronic Lymphocytic Leukemia.
鉴定 3'UTR 中三个体细胞突变及其与慢性淋巴细胞白血病淋巴细胞增多的反向相关性。
Cells. 2023 Nov 22;12(23):2687. doi: 10.3390/cells12232687.
4
An Optimized Single Nucleotide Polymorphism-Based Detection Method Suggests That Allelic Variants in the 3' Untranslated Region of Correlate with Treatment Response in Chronic Lymphocytic Leukemia Patients.一种优化的基于单核苷酸多态性的检测方法表明,慢性淋巴细胞白血病患者中3'非翻译区的等位基因变体与治疗反应相关。
Cancers (Basel). 2023 Jan 19;15(3):644. doi: 10.3390/cancers15030644.
5
Overexpression of wild type RRAS2, without oncogenic mutations, drives chronic lymphocytic leukemia.野生型 RRAS2 的过度表达,没有致癌突变,可导致慢性淋巴细胞白血病。
Mol Cancer. 2022 Feb 4;21(1):35. doi: 10.1186/s12943-022-01496-x.
6
Transcriptome-Guided Drug Repurposing for Aggressive SCCs.基于转录组学的侵袭性鳞癌药物再利用
Int J Mol Sci. 2022 Jan 17;23(2):1007. doi: 10.3390/ijms23021007.
7
Concepts and advances in cancer therapeutic vulnerabilities in RAS membrane targeting.癌症治疗中 Ras 膜靶向治疗弱点的概念和进展。
Semin Cancer Biol. 2019 Feb;54:121-130. doi: 10.1016/j.semcancer.2017.11.021. Epub 2017 Dec 2.
8
SIRT6 regulates Ras-related protein R-Ras2 by lysine defatty-acylation.SIRT6通过赖氨酸去脂肪酰化作用调节Ras相关蛋白R-Ras2。
Elife. 2017 Apr 13;6:e25158. doi: 10.7554/eLife.25158.
9
ERK1/2-induced phosphorylation of R-Ras GTPases stimulates their oncogenic potential.ERK1/2 诱导的 R-Ras GTPases 磷酸化刺激其致癌潜能。
Oncogene. 2016 Oct 27;35(43):5692-5698. doi: 10.1038/onc.2016.122. Epub 2016 Apr 18.
10
The sirtuin 3 expression profile is associated with pathological and clinical outcomes in colon cancer patients.沉默调节蛋白3的表达谱与结肠癌患者的病理及临床结果相关。
Biomed Res Int. 2014;2014:871263. doi: 10.1155/2014/871263. Epub 2014 Jul 1.